top of page

CHO-K1 CRE-Luciferase Reporter Cell Line

Item
Cat#
Price

Stable Cell Line

SNB-SP-0002

$19,80

Compound Test Services

CT-001

$1,850 per 384w plate

(Up To 16 cpds Dose)


Product Description


The CRE/CREB signaling pathway is a central intracellular mechanism that converts transient extracellular signals into long-term changes in gene expression. When first messengers like neurotransmitters or hormones bind to G-protein coupled receptors, they activate adenylate cyclase, leading to a rise in the second messenger cAMP. This cAMP then activates Protein Kinase A, allowing its catalytic subunits to translocate into the nucleus and phosphorylate the transcription factor CREB at serine residue 133. The phosphorylated CREB binds to the cAMP Response Element in the promoter regions of target genes and recruits coactivators such as CBP/p300. This ultimately initiates the transcription of specific genes involved in critical processes like neuronal plasticity, cell survival, and metabolism.

 

Screeningbio’s CHO-K1/CRE/Luciferase reporter gene cell line stable transfected with CREB response element and luciferase gene. Upon stimulated, cAMP/PKA pathway was activated and induce luciferase expression


Product Specifications

Target Type

Signal Pathway

Species

Human

HGNC Symbol


Accession Number


Parental Line

CHO-K1

Lot#

See Vial

Storage

Liquid Nitrogen


Data

CHO-K1/CRE-Luciferase Agonist Assay. CHO-K1/CRE-Luciferase reporter cells were treated with forskolin. The assay was run based on Promega ONE-GLOTM Luciferase Assay System. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 values were determined, using GraphPad Prism software.
CHO-K1/CRE-Luciferase Agonist Assay. CHO-K1/CRE-Luciferase reporter cells were treated with forskolin. The assay was run based on Promega ONE-GLOTM Luciferase Assay System. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 values were determined, using GraphPad Prism software.



Target Background


The CRE/CREB signaling pathway is a central intracellular mechanism that converts transient extracellular signals into long-term changes in gene expression. When first messengers like neurotransmitters or hormones bind to G-protein coupled receptors, they activate adenylate cyclase, leading to a rise in the second messenger cAMP. This cAMP then activates Protein Kinase A, allowing its catalytic subunits to translocate into the nucleus and phosphorylate the transcription factor CREB at serine residue 133. The phosphorylated CREB binds to the cAMP Response Element in the promoter regions of target genes and recruits coactivators such as CBP/p300. This ultimately initiates the transcription of specific genes involved in critical processes like neuronal plasticity, cell survival, and metabolism


Product Documentation



Related Products


bottom of page